Mayinglong Pharmaceutical Group Co., Ltd.

SHSE:600993 株式レポート

時価総額：CN¥11.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Mayinglong Pharmaceutical Group マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Youzhang Xia

最高経営責任者

CN¥1.8m

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet

Jun 19
Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet

Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%

May 07
Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel

Mar 22
Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel

CEO（最高経営責任者

Youzhang Xia (45 yo)

no data

在職期間

CN¥1,800,000

報酬

Mr. Youzhang Xia serves as General Manager and Director at Mayinglong Pharmaceutical Group Co., Ltd. and served as its Deputy General Manager and Secretary of the Board.